Include your BMI history, comorbidities, and relevant clinical trial data
That said, research does provide clues as to how quickly weight loss happens on tirzepatide
Typical schedules include: Starting Phase : Low initial dose (e.g., 2.5 mg/week) for 12 weeks to monitor response
The clinical application of GIP agonists for the treatment of diabetes is hampered by this increase in glucagon secretion, which has also been verified in both healthy and subjects with T2DM [19, 20]
Retatrutide appears in clinical-trial literature for obesity and metabolic disease (Phase III as of 2025-2026)
The results were impressive: 3 months: 5.26% average body weight reduction 6 months: 10.22% average body weight reduction 12 months: 15.12% average body weight reduction 18 months: 17.56% average body weight reduction 24 months: 16.99% average body weight reduction Weight loss was only part of the story: Brookfield employees demonstrated strong engagement, with 80% tracking their weight at least once per week and 67% completing their coaching sessions
